Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas.
Saved in:
| Title: | Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas. |
|---|---|
| Authors: | Munir M; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Sayed A; Department of Medicine, Rochester General Hospital, Rochester, NY, USA., Lee DH; Division of Cardiology, University of Pennsylvania, Thalheimer Center for Cardio- Oncology, Philadelphia, PA, USA., Awan F; Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Ghazi S; Cardio-Oncology Program, University of Texas Southwestern Medical Center, Dallas, TX, USA., Kim J; Cardio-Oncology Program, University of Texas Southwestern Medical Center, Dallas, TX, USA., Addison D; Cardio-Oncology Program, University of Texas Southwestern Medical Center, Dallas, TX, USA., Epperla N; Huntsman Cancer Institute, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA. naren.epperla@hci.utah.edu. |
| Source: | Journal of hematology & oncology [J Hematol Oncol] 2026 May 26; Vol. 19 (1). Date of Electronic Publication: 2026 May 26. |
| Publication Type: | Journal Article; Letter |
| Journal Info: | Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
